Vascularites double-positives ANCA et anti-MBG : mise au point sur les spécificités cliniques et thérapeutiques et comparaison aux deux vascularites éponymes
- 12 December 2019
- journal article
- review article
- Published by Elsevier BV in La Revue de Médecine Interne
- Vol. 41 (1), 21-26
- https://doi.org/10.1016/j.revmed.2019.10.334
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Outcome of Renal Transplantation in Patients With Both ANCA and Anti-GBM AntibodiesTransplantation, 2012
- ForewordKidney International Supplements, 2012
- Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune SystemPLOS ONE, 2012
- Asymptomatic Autoantibodies Associate with Future Anti-glomerular Basement Membrane DiseaseJournal of the American Society of Nephrology, 2011
- An autopsy-proven case of myeloperoxidase-antineutrophil cytoplasmic antibody-positive polyarteritis nodosa with acute renal failure and alveolar hemorrhageClinical and Experimental Nephrology, 2010
- Coexistent Wegener’s Granulomatosis and Goodpasture’s DiseaseThe Journal of Rheumatology, 2010
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisThe New England Journal of Medicine, 2010
- Characteristics and Outcome of Chinese Patients with Both Antineutrophil Cytoplasmic Antibody and Antiglomerular Basement Membrane AntibodiesNephron Clinical Practice, 2007
- Clinical features and outcome of patients with both ANCA and anti-GBM antibodiesKidney International, 2004
- The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodiesKidney International, 1999